# Safety and Efficacy of Human Adipose-Derived Stem Cell Exosomes in Acute Ischemic Stroke

> **NCT07398612** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 60 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **BIOLOGICAL:** Human Adipose-Derived Stem Cell Exosomes
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07398612
- **Lead sponsor:** Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-31
- **Primary completion:** 2028-05-31
- **Final completion:** 2028-08-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-02-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07398612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07398612, "Safety and Efficacy of Human Adipose-Derived Stem Cell Exosomes in Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07398612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*